These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Neuroendocrine markers of CNS drug effects. Johnstone EC; Ferrier IN Br J Clin Pharmacol; 1980 Jul; 10(1):5-21. PubMed ID: 6104974 [No Abstract] [Full Text] [Related]
6. Addiction: brain mechanisms and their treatment implications. Nutt DJ Lancet; 1996 Jan; 347(8993):31-6. PubMed ID: 8531549 [No Abstract] [Full Text] [Related]
7. [Progress in studies on the mechanism of substance addiction in central nervous system]. Zhang L; Zhou H; Tang Y; Liu Y Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2001 Jun; 18(2):296-8. PubMed ID: 11450558 [TBL] [Abstract][Full Text] [Related]
8. Opioid-dopamine interactions: implications for substance use disorders and their treatment. Volkow ND Biol Psychiatry; 2010 Oct; 68(8):685-6. PubMed ID: 20888455 [No Abstract] [Full Text] [Related]
9. Neurotransmitter and neuroendocrine abnormalities associated with cocaine use. Dackis C; Gold MS Psychiatr Med; 1985; 3(4):461-83. PubMed ID: 2829287 [No Abstract] [Full Text] [Related]
10. The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction. López-Moreno JA; González-Cuevas G; Moreno G; Navarro M Addict Biol; 2008 Jun; 13(2):160-87. PubMed ID: 18422831 [TBL] [Abstract][Full Text] [Related]
11. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs. Cunha-Oliveira T; Rego AC; Oliveira CR Brain Res Rev; 2008 Jun; 58(1):192-208. PubMed ID: 18440072 [TBL] [Abstract][Full Text] [Related]
12. Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists. Miller DK; Lever JR; Rodvelt KR; Baskett JA; Will MJ; Kracke GR Drug Alcohol Depend; 2007 Jul; 89(2-3):282-91. PubMed ID: 17368966 [TBL] [Abstract][Full Text] [Related]
13. The role of the endogenous cannabinoid system in drug addiction. Parolaro D; Rubino T Drug News Perspect; 2008 Apr; 21(3):149-57. PubMed ID: 18560613 [TBL] [Abstract][Full Text] [Related]
15. Divergent anatomical pattern of D1 and D3 binding and dopamine- and cyclic AMP-regulated phosphoprotein of 32 kDa mRNA expression in the Roman rat strains: Implications for drug addiction. Guitart-Masip M; Johansson B; Fernández-Teruel A; Cañete T; Tobeña A; Terenius L; Giménez-Llort L Neuroscience; 2006 Nov; 142(4):1231-43. PubMed ID: 17008016 [TBL] [Abstract][Full Text] [Related]
16. Genetics of dopamine receptors and drug addiction: a comprehensive review. Le Foll B; Gallo A; Le Strat Y; Lu L; Gorwood P Behav Pharmacol; 2009 Feb; 20(1):1-17. PubMed ID: 19179847 [TBL] [Abstract][Full Text] [Related]
17. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Koob GF Addiction; 2006 Sep; 101 Suppl 1():23-30. PubMed ID: 16930158 [TBL] [Abstract][Full Text] [Related]
18. Circuits, drugs, and drug addiction. Koob GF Adv Pharmacol; 1998; 42():978-82. PubMed ID: 9328061 [No Abstract] [Full Text] [Related]
19. Substance addiction treatable, says new report. Bull World Health Organ; 2004 Apr; 82(4):318. PubMed ID: 15309818 [No Abstract] [Full Text] [Related]